Pharmaceutical Executive July 4, 2024
The latest news for pharma industry insiders.
Emerging Data From Phase I Clinical Study for Pancreatic Cancer Show Stable Disease Activity
Preliminary results from study of small interfering RNA drug candidate, STP707, indicated the average days for stable disease in patients was 92.
Colder Temperatures May Worsen Asthma Symptoms in Pediatric Patients
However, more research is needed to effectively integrate this biomarker into individualized asthma management strategies for pediatric patients.
Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment
With the arrival of Lilly’s Kisunla, Alzheimer’s care could become more like treatment of cancer and rheumatoid arthritis and their regular infusions.
Boys & Girls Clubs of America and “The Chi” Star Jacob Latimore Team up to Host Mental...